The concentration of uric acid in patients with metabolic syndrome and cardiovascular diseases

Central European Journal of Medicine

Volumn 4, Issue 3, 2009, Pages 272-278

  Kowalski, Jan ^a   Krzemińska, Anna ^a   Banach, MacIej ^a   Pawlicki, Lucjan ^a   Śliwczyńska Rodziewicz, Dorota ^a   Barylski, Marcin ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular diseases; Hyperuricemia; Metabolic syndrome

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; WAIST HIP RATIO;

EID: 67651119921     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-009-0026-5     Document Type: Article

References (44)

1. Expert Panel on Detection Evaluation,Treatment of High Blood Cholesterol in Adults. 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2486 2497
2. E.S. Ford W.H. Giles 2003 A comparison of the prevalence of the metabolic syndrome using two proposed definitions Diabetes Care 26 575 581
3. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, April, 2005: http://www.idf.org/webdata
4. T.A. Pearson S.N. Blair S.R. Daniels R.H. Eckel J.M. Fair S.P. Fortmann 2002 AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases American Heart Association Science Advisory and Coordinating Committee, Circulation 106 388 391
5. S.M. Grundy B. Hansen S.C. Smith J.I. Cleeman R.A. Kahn 2004 American Heart Association: National Heart, Lung, and Blood Institute: American Diabetes Association Clinical management of metabolic syndrome report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management, Circulation 109 551 556
6. B. Isomaa P. Almgren T. Tuomi B. Forsen K. Lahti M. Nissen 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683 689
7. H.M. Lakka D.E. Laaksonen T.A. Lakka L.K. Niskanen E. Kumpusalo J. Tuomilehto 2002 The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2709 2716
8. V. Pasceri J.T. Willerson T. Yeh 2000 Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2165 2168
9. J.W. Yarnell P.M. Sweetnam A. Rumley G.D. Lowe 2000 Lifestyle and hemostatic risk factors for ischemic heart disease. The Caerphilly Study, Arterioscler Thromb. Vasc. Biol. 20 271 279
10. W. Doehner N. Schoene M. Rauchhaus F. Leyva-Leon D.V. Pavitt D.A. Reaveley 2002 Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2619 2624
11. E.D. Frohlich 1993 Uric acid: a risk factor for coronary heart disease JAMA 270 354 359
12. J.R. Stanton E.D. Freis 1947 Serum uric acid concentration in essential hypertension Proc. Soc. Exp. Biol. Med 66 193 194
13. J. Sudstrom L. Sullivan R.B. D'Agostino 2005 Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence Hypertension 45 28 33
14. A.B. Alper Jr. W. Chen L. Yau S.R. Srinivasan G.S. Berenson L.L. Hamm 2005 Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study Hypertension 45 34 38
15. D.S. Freedeman D.F. Williamson E.W. Grunter 1995 Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study Am. J. Epidemiol. 141 637 644
16. K. Kostka-Jeziorny A. Tykarski 2008 Zwia̧zek hiperurykemii z innymi czynnikami ryzyka sercowo-naczyniowego u pacjentów z pierwotnym, nieleczonym nadciśnieniem tȩtniczym w populacji badania RISK Nadciśnienie Tȩtnicze 12 190 199
17. D. Berkowitz 1966 Gout, hyperlipidemia and diabetes interrelationships JAMA 197 117 122
18. W.M. Mikkelsen 1965 The possible associations of hyperuricemia and/or gout with diabetes mellitus Arth. Reum. 8 853 863
19. D. Reed D. Labarthe R. Stallones 1972 Epidemiologic studies of serum uric acid levels among Micronesian Arth. Rheum. 15 38 43
20. A.R. Myers 1968 Relationship of serum uric acid to risk factors in coronary heart disease Am. J. Med. 45 520 534
21. K. Yano G. Rhoads A. Kagan 1977 Epidemiology of serum uric acid among 8000 Japanese men in Hawaii J. Chronic. Dis. 30 171 184
22. R. Klein B. Klein J. Cornoni 1973 Serum uric acid:its relationship to coronary heart disease, risk factors and cardiovascular disease Arch. Intern. Med. 132 401 409
23. J.B. Herman J.H. Medalie J.J. Groen 1967 Diabetes prevalence and serum uric acid. Observation among 10000 men in survey of ischemic heart disease in Israel Diabetes 16 858 868
24. J.B. Herman A. Keyman 1969 Hyperglycemia and uric acid Isr. J. Med. Sci. 5 1048 1053
25. J. Padova A. Patchefsky G. Onesti 1964 The effect of glucose loads on renal uric acid excretion in diabetic patients Metabolism. 13 507 511
26. A. Bedir M. Topbas F. Tanyeri M. Alvur N. Arik 2003 Leptin might be a regulator of serum uric acid concentration in humans Jpn. Heart J. 44 527 536
27. M. Modan H. Halkin A. Karasik 1987 Elevated serum uric acid - a face of hyperinsulinaemia Diabetologia 30 713 719
28. P.D. Patel R.R. Arora 2008 Uric acid and xanthine oxidase: perspectives in chronic heart failure Arch. Med. Sci. 4 219 225
29. C. Bickel H.J. Rupprecht S. Blankenberg G. Rippin G. Hafner A. Daunhauer K.P. Hofmann J. Meyer 2002 Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am. J. Cardiol. 89 12 17
30. A. Okrasa-Bylica A. Paradowski J. Matysek U. Czubek W. Piwowarska 2006 Sex hormone plasma levels in premenopausal women with coronary heart disease Cardiol. J. 13 423 426
31. E.S. Agamah S.R. Srinivasan L.S. Weber G.S. Berenson 1991 Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study J. Lab. Clin. Med. 118 241 249
32. W. Rathmann E. Funkhouser A.R. Dyer J.M. Roseman 1998 Relations of hyperuricemia with the various components of the insulin resistence syndrome in young black and white adults: the CARDIA study. Coronary artery risk development in young adults Ann. Epidemiol. 8 250 261
33. F. Matsuura S. Yamashita T. Nakamura 1998 Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity Metabolism 47 929 933
34. E. Bonora G. Targher M.B. Zenere 1996 Relationship of uroic acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study Int. J. Obes. 20 975 980
35. D.I. Feig R.J. Johnson 2003 Hyperuricemia in childhood primary hypertension Hypertension 42 247 252
36. Tykarski A., Mechanizm hiperurykemii oraz ocena wpływu leków hipotensyjnych na transport kwasu moczowego i jego prekursorów w nefronie w nadciśnieniu tȩtniczym pierwotnym. Praca habilitacyjna. Akademia Medyczna im. Karola Marcinkowskiego w Poznaniu. Poznań 1997 (in Polish)
37. J. Zalokar J. Lelllouch J.R. Claude D. Kuntz 1974 Epidemiology of serum uric acid and gout in Frenchmen J. Chronic. Dis. 27 59 75
38. J. Lee D. Sparrow S. Vokonas 1995 Uric acid and Coronary Heart Disease Risk: Evidence for a Role of Uric acid in the Obesity-Insulin Resistance Syndrome Am. J. Epidemiol. 142 3 8
39. C. Zoccali R. Maio F. Mallamaci G. Sesti F. Perticone 2006 Urid acid and endothelial dysfunction in essentiali hypertension J. Am. Soc. Nephrol. 17 1466 1471
40. T.S. Perlstein O. Gumieniak P.N. Hopkins L.J. Murphey N.J. Brown G.H. Williams 2004 Uric acid and the state of the intrarenal renin-angiotensin system in humans Kidney Int. 66 1465 1470
41. W. Doehner S.D. Anker G.S. Filippatos 2008 Uric acid in chronic heart failure: marker or therapeutic target? Arch. Med. Sci. 4 226 228
42. M. Barylski E. Kowalczyk M. Banach J. Ciecwierz L. Pawlicki J. Kowalski 2009 Plasma Total Antioxidant Activity in Comparison With Plasma NO and VEGF Levels in Patients With Metabolic Syndrome Angiology 60 87 92
43. M. Banach J. Rysz A. Goch D.P. Mikhailidis G.M. Rosano 2008 The role of trimetazidine after acute myocardial infarction Curr. Vasc. Pharmacol. 6 282 291
44. M. Boncler P. Gresner M. Nocun J. Rywaniak M. Dolnik J. Rysz 2007 Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation Biochim. Biophys. Acta. 1770 1651 1659